You are here

Article info

Article menu
Clinical/translational cancer immunotherapy
Original research
Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy

Authors

  • Ying Jing Clinical Research Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Xue Chen Early Clinical Trial Center, Office of National Drug Clinical Trial Institution, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Kunyan Li Early Clinical Trial Center, Office of National Drug Clinical Trial Institution, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Yaoming Liu Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Zhao Zhang Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Yiqing Chen Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Yuan Liu Center for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Yushu Wang Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Steven H Lin Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Lixia Diao Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Jing Wang Early Clinical Trial Center, Office of National Drug Clinical Trial Institution, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Yanyan Lou Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA PubMed articlesGoogle scholar articles
  • Douglas B Johnson Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA PubMed articlesGoogle scholar articles
  • Xiang Chen Department of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Hong Liu Department of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy, Xiangya Hospital, Central South University, Changsha, Hunan, China PubMed articlesGoogle scholar articles
  • Leng Han Department of Biochemistry and Molecular Biology, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, Texas, USACenter for Epigenetics and Disease Prevention, Institute of Biosciences and Technology, Texas A&M University, Houston, Texas, USADepartment of Translational Medical Sciences, College of Medicine, Texas A&M University, Houston, TX, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Leng Han; leng.han{at}tamu.edu; Dr Hong Liu; hongliu1014{at}csu.edu.cn; Dr Xiang Chen; chenxiangck{at}126.com
View Full Text

Citation

Jing Y, Chen X, Li K, et al
Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy
Journal for ImmunoTherapy of Cancer 2022;10:e003779. doi: 10.1136/jitc-2021-003779

Publication history

  • Accepted December 11, 2021
  • First published January 20, 2022.
Online issue publication 
October 18, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.